Alemtuzumab Plus Oral Dexamethasone, Followed By Alemtuzumab Maintenance Or Allogeneic Transplantation In Ultra High-Risk Cll: Interim Analysis Of A Phase Ii Study Of The Gcllsg And Fcgcll/Mw
BLOOD(2011)
摘要
Abstract 2854
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要